The relationship between hemoglobin levels and endothelial functions in diabetes mellitus

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 1, 2010, Pages 45-50

  Sonmez, Alper ^a   Yilmaz, Mahmut Ilker ^a   Saglam, Mutlu ^a   Kilic, Selim ^a   Eyileten, Tayfun ^a   Uckaya, Gokhan ^a   Caglar, Kayser ^a   Oguz, Yusuf ^a   Vural, Abdulgaffar ^a   Yenicesu, Mujdat ^a   Kutlu, Mustafa ^a   Kinalp, Can ^a   Zoccali, Carmine ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CHEMICAL ANALYSIS; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; FLOW MEDIATED DILATION; GLOMERULUS FILTRATION RATE; HEMODYNAMIC PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEINURIA; RISK ASSESSMENT; VASCULAR ENDOTHELIUM; VASODILATATION;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED;

EID: 75749138981     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05080709     Document Type: Article

References (23)

1. Berns JS, Fishbane S: CHOIR, CREATE, and anemia treatment in patients with CKD. Semin Dial 20: 277-279, 2007
2. Levin A: Understanding recent haemoglobin trials in CKD: Methods and lesson learned from CREATE and CHOIR. Nephrol Dial Transplant 22: 309-312, 2007
3. Vaziri ND: Anemia and anemia correction: Surrogate markers or causes of morbidity in chronic kidney disease? Nat Clin Pract Nephrol 4: 436-445, 2008
4. Szczech LA, Barnhart HX, Inrig JK, Reddan DN, Califf RM, Patel UD, Singh AK: Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int 74: 791-798, 2008
5. Jia L, Bonaventura C, Bonaventura J, Stamler JS: S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature 380: 221-226, 1996
6. Singel DJ, Stamler JS: Chemical physiology of blood flow regulation by red blood cells: The role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol 67: 99-145, 2005
7. Natali A, Toschi E, Baldeweg S, Casolaro A, Baldi S, Sironi AM, Yudkin JS, Ferrannini E: Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J 26: 464-471, 2005
8. Craig KJ, Williams JD, Riley SG, Smith H, Owens DR, Worthing D, Cavill I, Phillips AO: Anemia and diabetes in the absence of nephropathy. Diabetes Care 28: 1118-1123, 2005
9. In van Dijk DJ and Boner G: The treatment of patients with advanced renal disease. In: Management of Diabetic Nephropathy, edited by Boner G, Cooper ME, Informa Health Care, 2003, pp 189-198
10. Rossert J, Fouqueray B: Screening and management of patients with early chronic kidney disease. Acta Diabetol 41[Suppl 1]:S6 -S12, 2004
11. Yilmaz MI, Sonmez A, Saglam M, Gulec M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C: Hemoglobin is inversely related with flow-mediated dilatation in chronic kidney disease. Kidney Int 75: 1316-1321, 2009
12. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
15. Celermajer DS, Sorensen K, Ryalls M, Robinson J, Thomas O, Leonard JV, Deanfield JE: Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol 22: 854-858, 1993
16. Zoccali C: Endothelial dysfunction in CKD: A new player in town? Nephrol Dial Transplant 23: 783-785, 2008
17. Perticone F, Maio R, Mastroianni S, Greco L, Tripepi G, Mallamaci F, Zoccali C: Haemoglobin and endothelium-dependent vasodilation in uncomplicated, untreated subjects with essential hypertension (TH-PO251) [Abstract]. J Am Soc Nephrol 19 [Suppl]:165A, 2008
18. Joles JA, Stroes ES, Rabelink TJ: Endothelial function in proteinuric renal disease. Kidney Int Suppl 71: S57-S61, 1999
19. Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, Aydin A, Eyileten T, Ozcan O, Acikel C, Tasar M, Genctoy G, Erbil K, Vural A, Zoccali C: The determinants of endothelial dysfunction in CKD: Oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 47: 42-50, 2006
20. Caglar K, Yilmaz MI, Sonmez A, Cakir E, Kaya A, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Bilgi C, Oktenli C, Vural A, Zoccali C: ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease. Kidney Int 70: 781-787, 2006
21. Milsom AB, Jones CJ, Goodfellow J, Frenneaux MP, Peters JR, James PE: Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus. Diabetologia 45: 1515-1522, 2002
22. Billecke SS, Kitzmiller LA, Northrup JJ, Whitesall SE, Kimoto M, Hinz AV, D'Alecy LG: Contribution of whole blood to the control of plasma asymmetrical dimethylarginine. Am J Physiol Heart Circ Physiol 291: H1788-H1796, 2006
23. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995